Table 5.
Results of the calibration line and the analytical characteristics of the plasma analysis for the EISA-TOF and EISA-Q methods.
| EISA-TOF | EISA-Q | |||
|---|---|---|---|---|
|
| ||||
| Internal standard calibration method (0.5–100 μmol/L)a | ||||
|
| ||||
| L-2-HG | D-2-HG | L-2-HG | D-2-HG | |
| Slope ± SD | 0.131 ± 0.002 | 0.116 ± 0.002 | 0.124 ± 0.002 | 0.119 ± 0.003 |
| Intercept ± SD | 0.011 ± 0.003 | 0.021 ± 0.003 | 0.009 ± 0.003 | 0.013 ± 0.004 |
| R2 | 0.998 | 0.997 | 0.998 | 0.995 |
| LOQb | 0.5 μmol/L | 0.5 μmol/L | 0.5 μmol/L | 0.5 μmol/L |
| F-value of ANOVAc | 3268 | 2918 | 4046 | 1668 |
| Plasma | ||||
|
| ||||
| Trueness | % Mean recovery ± SD | |||
|
| ||||
| 10 μmol/L | 98 ± 4 | 100 ± 4 | 85 ± 6 | 96 ± 21 |
| 50 μmol/L | 97 ± 5 | 98.9 ± 0.1 | 99 ± 3 | 104 ± 4 |
| 70 μmol/L | 95 ± 8 | 99 ± 10 | 101 ± 4 | 104 ± 11 |
| Precision | RSD (%) | |||
|
| ||||
| Between injection repeatability (n=3)d | 3.6 | 2.8 | 2.3 | 6.8 |
| Measurement repeatability (n=3)e | 2.6 | 5.5 | 5.4 | 5.6 |
| Intermediate Measurement precision (n=9)f | 4.1 | 6.0 | 4.7 | 6.7 |
| Recovery (before and after the extraction) | % Mean recovery ± SD | |||
|
| ||||
| 106 ± 5 | 97 ± 4 | 86 ± 4 | 88 ± 14 | |
Nine standard solutions at concentration levels from 0.5 to 100 μmol/L for L-2-HG and D-2-HG. Each solution contains 10 μmol/L of L-2-HG-d3 and D-2-HG-d3. The calibration line was established by plotting the area ratio of each enantiomer versus the concentration using a 1/x2 weighting.
LOQ estimated as the lowest concentration in the calibration that can be quantified with acceptable trueness (between 70–130%) and precision (coefficient of variation <30%).
F-value for ANOVA test that confirms that experimental data fit to a linear model. In all cases the p-values were lower than 0.05.
Three consecutive injections of a plasma sample spiked with 10 μmol/L of L-2-HG, 10 μmol/L of D-2-HG, 10 μmol/L of L-2-HG-d3 and 10 μmol/L of D-2-HG-d3.
Three replicates of plasma samples spiked with 10 μmol/L of L-2-HG, 10 μmol/L of D-2-HG, 10 μmol/L of L-2-HG-d3 and 10 μmol/L of D-2-HG-d3 injected in triplicate on the same day.
Three replicates of plasma samples spiked with 10 μmol/L of L-2-HG, 10 μmol/L of D-2-HG, 10 μmol/L of L-2-HG-d3 and 10 μmol/L of D-2-HG-d3 injected during three consecutive days.